INVO Fertility, Inc. IVF

IVF Company Overview

INVO Fertility, Inc. is a U.S.-based healthcare and fertility company focused on expanding access to assisted reproductive technology (ART) services. The company operates in the fertility and reproductive healthcare industries and is best known for developing the INVOcell device, an intravaginal culture system designed to facilitate fertilization and early embryo development inside the patient’s body rather than exclusively in a traditional laboratory incubator environment. The company generates revenue through fertility clinic operations, physician partnerships, fertility-related procedures, and sales or licensing associated with its fertility technology platform.

The company’s strategic positioning centers on providing lower-cost fertility treatment alternatives relative to conventional in vitro fertilization (IVF) procedures while expanding fertility care access in underserved markets. INVO Fertility evolved from a medical device-focused business into an operator and partner of fertility clinics through acquisitions, clinic investments, and physician collaborations. Public disclosures, including SEC filings and investor materials, indicate that the company has increasingly emphasized clinic ownership and operational integration as part of its long-term growth model.